Skip to content

Clinical trials

Hemorrhage trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Country / region: Taiwan Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20081
20092
20102
20141
20161
20181
20202
20211
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status5
Recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital3
Pfizer3
Far Eastern Memorial Hospital2
National Cheng-Kung University Hospital2
AstraZeneca1
Boehringer Ingelheim1
Feng Yuan Hospital, Ministry of Health and Welfare1
Idorsia Pharmaceuticals Ltd.1
National Science and Technology Council, Taiwan1
Taipei Medical University Shuang Ho Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage17
Hemophilia A3
Hemophilia B3
Peptic Ulcer3
Stroke2
Acute Coronary Syndrome1
Atrial Fibrillation1
Bacteremia1
Cataplexy1
Constriction, Pathologic1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.